x Health Men's Health Children's Health Nutrition and Wellness Reproductive Health Health & Science Digital News Videos Opinions Cartoons Education E-Paper Lifestyle & Entertainment Nairobian Entertainment Eve Woman Travelog TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise BULK SMS E-Learning Digger Classified The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS
Login ×
BTV
VAS
DCX
RMS

Kenya's Covid-19 cases up by 219

Health & Science - By Jael Mboga | January 5th 2021 at 04:14:21 GMT +0300

Kenya has today recorded 219 positive coronavirus cases from a sample size of 5,413.

The country's total infections tally now stands at 97,127.

From the new cases, 170 are Kenyans while 49 are foreigners.

In a statement to newsrooms on Tuesday, Health Cabinet Secretary Mutahi Kagwe said 136 were men and 83 were women. “The youngest is a two-month-old infant while the oldest is 90.”

Covid 19 Time Series

 

Nairobi led in the number of new cases with 141, followed by Mombasa (26), Uasin Gishu (7), Kisumu (6) and Machakos (5), among others.

Regarding recoveries, 83 recovered from the home-based care programme while 17 were discharged from various hospitals. The total recoveries now stand at 79,357.

Four patients have succumbed to the disease, pushing the cumulative fatalities to 1,690.

According to CS Kagwe, there are 614 patients admitted in various health facilities countrywide, with 2,940 being in home-based isolation and care.

Meanwhile, the approval of the Oxford/AstraZeneca vaccine in India also marked the start of the manufacture of the jab for Kenya and other developing countries.

In a deal with Astra Zeneca, the Serum Institute of India (SII) will manufacture one billion doses for sale to poor countries at no profit.

Another 300 million doses of the vaccine, called Covidshield in India, will be made available to the Covax facility, which is assisting poor countries to access Covid-19 jabs.

Kenya has applied for 24 million free doses and an additional for-pay 12 million doses through the Covax facility.

Initial reports from Covax indicate Kenya will get doses to cover 1.4 million individuals by June and the rest of the 24 million doses in the second half of this year. The 12 million for-pay doses will be delivered as they become available in 2022.

The UK, which approved the AstraZeneca vaccine last week, has committed about Sh82 billion (£548 million) to the Covax facility.

“This will go towards helping developing countries access vaccines, including the Oxford/AstraZeneca candidate,” the British High Commission in Nairobi told The Standard in an email.

These doses will mainly come from SII, which is the world’s biggest vaccines manufacturer by volume, producing about 1.5 billion doses of various inoculants annually.

“We are ready to roll-out in the coming weeks,” tweeted SII’s chief executive Adar Poonawalla after the approval on Sunday morning.

But Poonawalla said SII will prioritise India first before distributing to other countries. “It's very important we take care of our country first, then go on to Covax and then other bilateral deals.”

He also said for export, the vaccine must have been approved by the World Health Organisation (WHO) and licensed in importing countries.

Be The First To Comment

Top Stories

Covid-19 jab: Will the poor have a fair shot?
Health & Science - By Dominic Omondi


Relief as nurses end strike
Health & Science - By Graham Kajilwa


My wife’s genes are killing our children
Health & Science - By Lydiah Nyawira


Vaccine will be rolled out in June, says State
Health & Science - By Graham Kajilwa


Why Kenyans might have to wait until next year for elusive Covid-19 vaccine
Health & Science - By Mercy Kahenda


Covid-19: Two dead as 280 test positive
Health & Science - By Mercy Asamba


Tanzania changes tune, issues covid-19 rules
Health & Science - By Jennifer Anyango


FDA staff: Johnson & Johnson's one-shot Covid-19 vaccine effective, safe
Health & Science - By Reuters


Kenya records first case of rare mad cow disease in human
Health & Science - By Gatonye Gathura


Fears brain-swelling Nipah virus with up to 75% death rate 'may become next pandemic'
Health & Science - By Mirror


Latest Stories

Relief as nurses end strike
Health & Science - By Graham Kajilwa


Pfizer vaccine found 94% effective in real world
Health & Science - By Reuters


New coronavirus variant identified in New York: researchers
Health & Science - By Reuters


Covid-19 jab: Will the poor have a fair shot?
Health & Science - By Dominic Omondi


Covid-19 infections rise by 277
Health & Science - By Betty Njeru


FDA staff: Johnson & Johnson's one-shot Covid-19 vaccine effective, safe
Health & Science - By Reuters


Covid-19: what happens if some countries don’t vaccinate?
Health & Science - By WEF


Tanzania changes tune, issues covid-19 rules
Health & Science - By Jennifer Anyango


WHO to compensate for serious jab side effects
Health & Science - By Xinhua


Covid-19: Two dead as 280 test positive
Health & Science - By Mercy Asamba


//

Stay Ahead!

Access premium content only available
to our subscribers.

Or Login With Your Standard Account
Support independent journalism
×
Create An Account
Support independent journalism
I have an account Log in
Reset Password
Support independent journalism
Log in